A recent study based on a population of 300 GC identified 40 genes specifically expressed in diffuse or intestinal GC [12] and three genes associated with the patients’ prognosis, namely EFEMP1 and FRZB in G-DIF and KRT23 in G-INT. This evidence concerns the gene EFEMP1 and gastric cancer.